Skip to content
value.today

Pivot Bio, Inc.

Total raised
$622 M
4 rounds on record
Latest round
$435 M
Jun 2021
First round on record
Jan 2016
Today
Private
No later event on record

Funding rounds

4 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Pivot Bio, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Jun 2021$435 MNo. 4$250 million to $1 billion

Pivot Bio, Inc.: Raise no. 4, Jun 2021

Investors in this round

19 investors had bought by the notice of Aug 4, 2021: 19 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$435 M of $435 M offered; $0 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Alvin Cooper Tamsir · Executive Officer, Director
  • Karsten Temme · Executive Officer, Director
  • Charles Cooper Rinzler · Director
  • Christopher Cooper Abbott · Director
  • Lisa Cooper Safarian · Director
  • Matt Ocko · Director
  • Ryan Cooper Rakestraw · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Karsten Temme, Chief Executive Officer. Source: SEC Form D, newest notice filed Aug 4, 2021. Read the notice at the SEC.

equitySEC
Jan 2020$100 MNo. 3$50 to $250 million

Pivot Bio, Inc.: Raise no. 3, Jan 2020

Investors in this round

13 investors had bought by the notice of May 12, 2020: 13 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$100 M of $100 M offered
Smallest investment taken
no minimum stated
What was sold
equity, other: Series C Preferred Stock and Common Stock issuable upon the conversion thereof.
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Alvin Cooper Tamsir · Executive Officer, Director
  • Karsten Temme · Executive Officer, Director
  • Charles Cooper Rinzler · Director
  • Dheeraj Cooper Mehta · Director
  • Matt Ocko · Director
  • Roger Wyse · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Karsten Temme, Chief Executive Officer. Source: SEC Form D, newest notice filed May 12, 2020. Read the notice at the SEC.

equitySEC
Sep 2018$71 MNo. 2$50 to $250 million

Pivot Bio, Inc.: Raise no. 2, Sep 2018

Investors in this round

15 investors had bought by the notice of Oct 29, 2018: 15 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$71 M of $71 M offered; $0 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, other: Series B Preferred Stock and Common Stock issuable upon the conversion thereof.
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Alvin Tamsir · Executive Officer, Director
  • Karsten Temme · Executive Officer, Director
  • Charles Cooper Rinzler · Director
  • Dheeraj Cooper Mehta · Director
  • Matt Ocko · Director
  • Roger Wyse · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Karsten Temme, Ceo. Source: SEC Form D, newest notice filed Oct 29, 2018. Read the notice at the SEC.

equitySEC
Jan 2016$16 MNo. 1$10 to $50 million

Pivot Bio, Inc.: Raise no. 1, Jan 2016

Investors in this round

10 investors had bought by the notice of Mar 22, 2016: 10 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$16 M of $16 M offered
Smallest investment taken
no minimum stated
What was sold
equity, other: Sale and issuance of Series A Preferred Stock and the underlying shares of Common Stock issuable upon the conversion thereof.
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Alvin Tamsir · Executive Officer, Director
  • Karsten Temme · Executive Officer, Director
  • John Hamer · Director
  • Matt Ocko · Director
  • Roger Wyse · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Karsten Temme, President and Chief Executive Officer. Source: SEC Form D and 1 amendment, newest notice filed Mar 22, 2016. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Pivot Bio, Inc. chose not to state its revenue in its newest notice of a funding round (Aug 2021).

    SEC Form D · Aug 2021

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Aug 2021

That is all the official record says: Pivot Bio, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Pivot Bio, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 4 rounds above had up to 19 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Pivot Bio, Inc.
NameRoleNamed in
Alvin Cooper TamsirExecutive officerAug 2021
Karsten TemmeExecutive officerAug 2021
Alvin TamsirExecutive officerOct 2018
Alvin Cooper TamsirDirectorAug 2021
Charles Cooper RinzlerDirectorAug 2021
Christopher Cooper AbbottDirectorAug 2021
Karsten TemmeDirectorAug 2021
Lisa Cooper SafarianDirectorAug 2021
Matt OckoDirectorAug 2021
Ryan Cooper RakestrawDirectorAug 2021
Dheeraj Cooper MehtaDirectorMay 2020
Roger WyseDirectorMay 2020
Alvin TamsirDirectorOct 2018
John HamerDirectorMar 2016